Sumitomo Chemical Logo
JP3401400001
853490
SOMMF

Sumitomo Chemical

Loading quotes...

Forecast

There is no analyst data available for this company.


  • Sumitomo Chemical falls after Gotham short-seller report and weak market

    Sumitomo Chemical’s stock fell 3.6% to 494.1 yen, weighed down by a Gotham City Research report accusing subsidiary Sumitomo Pharma of misreporting the fiscal 2025 accounts by up to 165 billion yen. The short-seller alleges manipulated receivables and singles out a 48 billion yen dividend announced shortly before year-end by a Swiss unit. Additional pressure came from a weaker overall market in Japan and investor caution ahead of upcoming quarterly results. » More on de.investing.com


  • Sumitomo Chemical creates joint venture with Samsung for glass-core substrates

    Sumitomo Chemical’s stock rose 7.1% to „558.8 after Dongwoo Fine Chem signed a binding agreement with Samsung Electro-Mechanics. The joint venture (provisionally named “GlaSSEM”) will produce glass-core substrates for advanced packaging of AI chips, involves about 480 billion won in investment and foresees a 66%/34% ownership split in favor of Samsung. Formation is planned by the end of 2026, with mass production targeted for the second half of 2027; Mizuho upgraded its rating to “Buy” while lowering the price target to „720. » More on de.investing.com


  • Sumitomo Chemical shares rise after surprisingly strong quarterly profit

    Sumitomo Chemical reported Q3 EPS of „29.12 versus a forecast of -„1.73, significantly beating expectations; revenue was „610.93 billion (forecast „586.5 billion). The stock jumped 10.64% and closed at „506.5, near the 52-week high. Drivers were strong sales in the pharmaceuticals and semiconductor materials segments; core operating profit rose year‑on‑year to „186.8 billion. The company plans further structural reforms and expects a full‑year core operating profit of „200 billion and a net profit of „55 billion. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2026, Sumitomo Chemical has already paid €0.0404 in dividends. The last payout was in June.

Financials

In the last quarter, Sumitomo Chemical had revenue of €3.11B and net profit of €219.71M
(EUR) Jun 2026
YoY
Revenue 3.11B 0.35%
Gross profit 1.05B 8.34%
Net profit 219.71M 923.36%
EBITDA 418.93M 14.80%

Fundamentals

Metric Value
Market capitalization
€4.97B
Number of shares
1.65B
52-week high/low
€3.37 - €2.26
Dividend yield
2.48%
Dividends TTM
€0.0735
Beta
0.48
P/E ratio
8.64
PEG ratio
0.01
P/B ratio
0.84
P/S ratio
0.39

Company profile

Sumitomo Chemical Company, Limited ist weltweit in den Bereichen Petrochemie und Kunststoffe, Energie und funktionelle Materialien, IT-bezogene Chemikalien, Gesundheits- und Pflanzenschutzmittel, Arzneimittel und anderen GeschĂ€ftsbereichen tĂ€tig. Das Segment Petrochemikalien und Kunststoffe bietet synthetische Harze wie Polyethylen, Polypropylen und Polymethylmethacrylat, Rohstoffe fĂŒr synthetische Fasern und verschiedene Industriechemikalien an. Das Segment Energy & Functional Materials bietet Aluminiumoxid und Aluminiumprodukte fĂŒr Energieprodukte, Polymeradditive und Kautschukchemikalien, synthetischen Kautschuk fĂŒr Reifen, Schuhe, Baumaterialien und andere Anwendungen sowie technische Kunststoffe und Materialien fĂŒr Lithium-Ionen-SekundĂ€rbatterien zur Verwendung in elektronischen Komponenten und Fahrzeugen der nĂ€chsten Generation. Das Segment IT-Related Chemicals bietet polarisierende Folien, Sensorplatten fĂŒr Touchscreens und Farbresists fĂŒr LC- und OLED-Displays, Photoresists und hochreine Chemikalien fĂŒr die Halbleiterherstellung sowie Verbindungshalbleitermaterialien fĂŒr Antennenschalter und andere Komponenten von KommunikationsendgerĂ€ten. Das Unternehmenssegment Health & Crop Sciences bietet Pflanzenschutzchemikalien, DĂŒngemittel, FuttermittelzusĂ€tze und Haushaltsinsektizide, pharmazeutische Wirkstoffe und Zwischenprodukte sowie Produkte zur BekĂ€mpfung von Infektionskrankheiten an. Das Segment Pharmazeutika bietet verschreibungspflichtige und diagnostische Arzneimittel an. Das Unternehmenssegment Andere liefert elektrische Energie und Dampf, entwirft, baut und ĂŒberwacht chemische Anlagen, bietet Transport- und Lagerungsdienste an und fĂŒhrt physikalische Eigentums- und Umweltanalysen durch. Das Unternehmen arbeitet mit Ginkgo Bioworks zusammen und kĂŒndigt Sumitomo Chemical an, um biobasierte Chemikalien zu entwickeln. Die Sumitomo Chemical Company, Limited wurde 1913 gegrĂŒndet und hat ihren Hauptsitz in Tokio, Japan.

Name
Sumitomo Chemical
CEO
Nobuaki Mito
Headquarters Tokyo, ty
Japan
Website
Sector
Materials
Industry
Chemicals
IPO
10/02/2020
Employees 27,491

Ticker symbols

Exchange Symbol
Pnk
SOMMF
Japan Exchange Group
4005.T
Frankfurt
SMM.F
DĂŒsseldorf
SMM.DU
MĂŒnchen
SMM.MU
đŸȘ

Parqet  uses cookies. Learn more